Antimicrobial peptides: Effectors of innate immunity in the skin

Advances in Dermatology

Volumn 21, Issue , 2005, Pages 357-374

  Barak, Orr ^a   Treat, James R ^b   James, William D ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29244454321     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2005.07.001     Document Type: Review

References (56)

1. Ganz T: Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720, 2003.
2. Ganz T: Immunology. Versatile defensins. Science 298:977-979, 2002.
3. Finlay BB, Hancock RE: Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2:497-504, 2004.
4. Hengge UR, Cusini M: Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum. Br J Dermatol 149:15S-19S, 2003.
5. Agerberth B, Charo J, Werr J, et al: The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086-3093, 2000.
6. Frohm M, Agerberth B, Ahangari G, et al: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258-15263, 1997.
7. Murakami M, Ohtake T, Dorschner RA, et al: Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 81:845-850, 2002.
8. Frohm Nilsson M, Sandstedt B, Sorensen O, et al: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 67:2561-2566, 1999.
9. Sorensen O, Arnljots K, Cowland JB, et al: The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796-2803, 1997.
10. Panyutich A, Shi J, Boutz PL, et al: Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immun 65:978-985, 1997.
11. Tomasinsig L, Scocchi M, Di Loreto C, et al: Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J Leukoc Biol 72:1003-1010, 2002.
12. Zaiou M, Gallo RL: Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 80:549-561, 2002.
13. Zanetti M, Gennaro R, Romeo D: Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374:1-5, 1995.
14. Zaiou M, Nizet V, Gallo RL: Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810-816, 2003.
15. Bals R, Wilson JM: Cathelicidins: A family of multifunctional antimicrobial peptides. Cell Mol Life Sci 60:711-720, 2003.
16. Gutsmann T, Fix M, Larrick JW, et al: Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. J Membr Biol 176:223-236, 2000.
17. De Y, Chen Q, Schmidt AP, et al: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069-1074, 2000.
18. Niyonsaba F, Someya A, Hirata M, et al: Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31:1066-1075, 2001.
19. Nizet V, Ohtake T, Lauth X, et al: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457, 2001.
20. Dorschner RA, Pestonjamasp VK, Tamakuwala S, et al: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A streptococcus. J Invest Dermatol 117:91-97, 2001.
21. Murakami M, Lopez-Garcia B, Braff M, et al: Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172:3070-3077, 2004.
22. Murakami M, Ohtake T, Dorschner RA, et al: Cathelicidin antimicrobial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119:1090-1095, 2002.
23. Mathews M, Jia HP, Guthmiller JM, et al: Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67:2740-2745, 1999.
24. Okumura K, Itoh A, Isogai E, et al: C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 212:185-194, 2004.
25. Putsep K, Carlsson G, Boman HG, et al: Deficiency of antibacterial peptides in patients with Morbus Kostmann: An observation study. Lancet 360:1144-1149, 2002.
26. Yang D, Biragyn A, Kwak LW, et al: Mammalian defensins in immunity: More than just microbicidal. Trends Immunol 23:291-296, 2002.
27. Fulton C, Anderson GM, Zasloff M, et al: Expression of natural peptide antibiotics in human skin. Lancet 350:1750-1751, 1997.
28. 27a. Ali RS, Falconer A, Ikram M, et al: Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 117:106-111, 2001.
29. Schonwetter BS, Stolzenberg ED, Zasloff MA: Epithelial antibiotics induced at sites of inflammation. Science 267:1645-1648, 1995.
30. Harder J, Bartels J, Christophers E, et al: A peptide antibiotic from human skin. Nature 387:861, 1997.
31. Nomura I, Goleva E, Howell MD, et al: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-3269, 2003.
32. Ong PY, Ohtake T, Brandt C, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160, 2002.
33. Milner SM, Ortega MR: Reduced antimicrobial peptide expression in human burn wounds. Burns 25:411-413, 1999.
34. Supp DM, Karpinski AC, Boyce ST: Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. Burns 30:643-648, 2004.
35. Oren A, Ganz T, Liu L, et al: In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74:180-182, 2003.
36. Oppenheim JJ, Biragyn A, Kwak LW, et al: Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62:17S-21S, 2003.
37. Yang D, Chertov O, Bykovskaia SN, et al: Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528, 1999.
38. Biragyn A, Ruffini PA, Leifer CA, et al: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029, 2002.
39. Philpott MP: Defensins and acne. Mol Immunol 40:457-462, 2003.
40. Farrar MD, Ingham E: Acne: Inflammation. Clin Dermatol 22:380-384, 2004.
41. Chronnell CM, Ghali LR, Ali RS, et al: Human beta defensin-1 and -2 expression in human pilosebaceous units: Upregulation in acne vulgaris lesions. J Invest Dermatol 117:1120-1125, 2001.
42. Fieguth A, Feldbrugge H, Gerich T, et al: The time-dependent expression of fibronectin, MRP8, MRP14 and defensin in surgically treated human skin wounds. Forensic Sci Int 131:156-161, 2003.
43. Ortega MR, Ganz T, Milner SM: Human beta defensin is absent in burn blister fluid. Burns 26:724-726, 2000.
44. Zasloff M: Antimicrobial peptides in health and disease. N Engl J Med 347:1199-1200, 2002.
45. Schittek B, Hipfel R, Sauer B, et al: Dermcidin: A novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2:1133-1137, 2001.
46. Flad T, Bogumil R, Toison J, et al: Detection of dermcidin-derived peptides in sweat by ProteinChip technology. J Immunol Methods 270:53-62, 2002.
47. Rieg S, Garbe C, Sauer B, et al: Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol 151:534-539, 2004.
48. Porter D, Weremowicz S, Chin K, et al: A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci U S A 100:10931-10936, 2003.
49. Sieprawska-Lupa M, Mydel P, Krawczyk K, et al: Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679, 2004.
50. Jin T, Bokarewa M, Foster T, et al: Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169-1176, 2004.
51. 2-Macroglobulin- proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 279:52820-52823, 2004.
52. Burtnick MN, Woods DE: Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother 43:2648-2656, 1999.
53. Miller SI, Pulkkinen WS, Selsted ME, et al: Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun 58:3706-3710, 1990.
54. Fedtke I, Gotz F, Peschel A: Bacterial evasion of innate host defenses: The Staphylococcus aureus lesson. Int J Med Microbiol 294:189-194, 2004.
55. Campos MA, Vargas MA, Regueiro V, et al: Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72:7107-7114, 2004.
56. Shafer WM, Qu X, Waring AJ, et al: Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A 95:1829-1833, 1998.